Safety and Efficacy of T Cell Genetic Immunotherapy for HIV - Related Studies

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

This study is ongoing, but not recruiting participants.

Study NCT00131560. Last updated on June 25, 2008. Information provided by VIRxSYS Corporation

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		HIV Infection

2	Additional conditions recognized in this trial
		Acquired Immunodeficiency Syndrome
		HIV Infections
		Infection

3	More general conditions related to this trial
		Immune System Diseases
		Immunologic Deficiency Syndromes
		Lentivirus Infections
		Retroviridae Infections
		RNA Virus Infections
		Sexually Transmitted Diseases
		Sexually Transmitted Diseases, Viral
		Slow Virus Diseases
		Virus Diseases

4	Interventions listed in this trial
		VRX496-Modified Autologous T cells

5	Sponsors listed in this trial
		VIRxSYS Corporation